BRIEF-Protagonist Therapeutics Posts Q4 Loss Per Share Of $0.48

路透社 · Mar 11, 2021 06:49

March 10 (Reuters) - Protagonist Therapeutics Inc :
   * PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND CORPORATE UPDATE
   * Q4 LOSS PER SHARE $0.48
   * Q4 EARNINGS PER SHARE ESTIMATE $-0.48 -- REFINITIV IBES DATA
   * CASH POSITION TO FUND PLANNED OPERATIONS THROUGH FIRST HALF OF 2024

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

BRIEF-Protagonist Therapeutics Posts Q4 Loss Per Share Of $0.48

Risk Disclaimer